- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
💊
Medogen
IM Injection
Generic Name
Medroxyprogesterone Acetate
Manufacturer
Incepta Pharmaceuticals Ltd.
Unit Price
1 ml vial: ৳ 50.00
🔹 Indications
Medogen indicated for:
🔹 Pharmacology
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Dosage & Administration
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Interaction
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Contraindications
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Side Effects
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Pregnancy & Lactation
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Precautions & Warnings
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
🔹 Storage Conditions
Medogen indicated for:
- Ovulation suppression
- The treatment of endometriosis.
- Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
- The treatment of hormonally-dependant recurrent breast cancer in post-menopausal women.
💡 Frequently Asked Questions
Medogen indicated for:
Ovulation suppression
The treatment of endometriosis.
Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
The treatment of hormonally-dependant recurrent breast cancer in post...
Medogen indicated for:
Ovulation suppression
The treatment of endometriosis.
Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
The treatment of hormonally-dependant recurrent breast cancer in post...
Medogen indicated for:
Ovulation suppression
The treatment of endometriosis.
Adjunctive and/or pallivative treatment of recurrent and/or metastatic endometrial or renal carcinoma.
The treatment of hormonally-dependant recurrent breast cancer in post...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.